Statistics
Publications
3
Citations
48
H-Index
3
Active since
2018
Anastasiya Bykova is an author at Russian Research Institute of Hematology and Transfusiology specializing in receptor tyrosine kinase signaling, tyrosine kinase inhibitor therapy, and pharmacology.
Publications per year
2018–2020
3
3
Phase-1 Study of PF-114 Mesylate in CML Failing Prior Tyrosine Kinase-Inhibitor Therapy
Anna Turkina, Olga Vinogradova, Elza Lomaia et al. · Blood · 2018 · 15 citations
Ekaterina Chelysheva, Oleg Shukhov, Anastasiya Bykova et al. · Clinical Lymphoma Myeloma & Leukemia · 2020 · 15 citations
Medicine, Oncology, Pharmacology +14
1–3 of 3